Results 241 to 250 of about 296,327 (357)

Impact of left ventricular ejection fraction on the effect of beta-blocker therapy on 1-year mortality in acute coronary syndrome patients. [PDF]

Eur Heart J Cardiovasc Pharmacother
Maeder MT, Foster-Witassek F, Radovanovic D, Roffi M, Pedrazzini G, Rickli H.   +5 more
europepmc   +1 more source

Body Surface Area-Weighted Left Ventricular Ejection Fraction Enhances Prediction Accuracy of OPCABG Outcomes: A Large Multi-Center Cohort Study. [PDF]

Rev Cardiovasc Med
Wei Z, Zhu Z, Li Y, Li C, Liu N, Lu J, Wu M, Wang H, Xu D, Chen Y, Lai Y, Zhang H.   +11 more
europepmc   +1 more source

Heart failure outcomes by left ventricular ejection fraction in a contemporary region‐wide patient cohort [PDF]

Johan Sundström, Johan Ärnlöv, Stelios Karayiannides, Johan Bodegård, Karolina Ersmark, Stefan Gustafsson, Thomas Cars, Maria Svensson, Anna Norhammar   +8 more
openalex   +1 more source

Heart failure in two male patients with late‐onset Fabry mutation (IVS4 + 919G > A)

ESC Heart Failure, Volume 12, Issue 2, Page 1508-1513, April 2025.
Xufei Yang, Chunlan Deng, Xiaogang Guo, Hui Yan   +3 more
wiley   +1 more source

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon, Guillaume Trebuchet, Anthony Criquet, Matthieu de Kalbermatten, Eric Saloux, Alain Manrique, Pierre‐Yves Marie, Deepak L. Bhatt, Scott D. Solomon, Gilles Montalescot, David E. Newby, Faiez Zannad, on behalf of the EXCELLENT Trial Investigators   +17 more
wiley   +1 more source

Untangling the prognostic value of diastolic dysfunction, NT-proBNP, and frailty in older patients with preserved left ventricular ejection fraction without valvular disease. [PDF]

BMC Geriatr
de Terwangne C, Vaes B, Pasquet A, Boland B, Pouleur AC, Degryse JM.   +5 more
europepmc   +1 more source

Real‐world characteristics and treatment of cardiac transthyretin amyloidosis: A multicentre, observational study

ESC Heart Failure, Volume 12, Issue 2, Page 1203-1216, April 2025.
The 366 patients diagnosed with transthyretin amyloidosis cardiomyopathy (ATTR‐CM) were analyzed regarding their clinical characteristics in the first year after approval of tafamidis 61 mg for ATTR‐CM in Germany. Nearly two‐thirds of the patients were in an advanced disease stage and 64% met the key criteria of the “Transthyretin Amyloidosis ...
Richard J. Nies, Svenja Ney, Ingrid Kindermann, Yvonne Bewarder, Angela Zimmer, Fabian Knebel, Katrin Hahn, Sebastian Spethmann, Peter Luedike, Lars Michel, Tienush Rassaf, Maria Papathanasiou, Stefan Störk, Vladimir Cejka, Amin Polzin, Fabian Voss, Malte Kelm, Bernhard Unsöld, Christine Meindl, Michael Paulus, Ali Yilmaz, Bishwas Chamling, Caroline Morbach, Roman Pfister   +23 more
wiley   +1 more source

The impact of decreased left ventricular ejection fraction on neutrophil extracellular trap (NET) formation measured by citrullinated histone H3 (citH_3) concentration. [PDF]

Sci Rep
Urbanowicz T, Krasińska B, Spasenenko I, Gabriel K, Dziatkiewicz-Warkocz P, Mertowski S, Bojarski K, Grywalska E, Filipiak K, Tykarski A, Krasiński Z, Jemielity M, Gil L, Rupa-Matysek J.   +13 more
europepmc   +1 more source

Phenotyping patients with chronic obstructive pulmonary disease and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 900-911, April 2025.
Central illustration. Abbreviations: ACEi, angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; ARNi, angiotensin‐receptor‐neprilysin inhibitor; CI, confidence interval; COPD, chronic obstructive pulmonary disease; CRT, cardiac resynchronization therapy; CV, cardiovascular; EF, ejection fraction; eGFR, estimated glomerular ...
Peter Moritz Becher, Felix Lindberg, Lina Benson, Camilla Hage, Ulf Dahlström, Stephan Rosenkranz, Francesco Cosentino, Giuseppe M.C. Rosano, Stefan Blankenberg, Paulus Kirchhof, Frieder Braunschweig, Lars H. Lund, Gianluigi Savarese   +12 more
wiley   +1 more source

Ventricular Tachycardia Ablation in Patients With Severely Decreased Left Ventricular Ejection Fraction. [PDF]

J Cardiovasc Electrophysiol
Ghannam M, Christian-Miller N, Liang J, Deshmukh A, Arps K, Latchamsetty R, Crawford T, Jongnarangsin K, Oral H, Morady F, Bogun F.   +10 more
europepmc   +1 more source